Ballentine Partners’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$244K Buy
22,046
+400
+2% +$2.45K ﹤0.01% 912
2026
Q1
$166K Sell
21,646
-2,019
-9% -$15.4K ﹤0.01% 958
2025
Q4
$230K Buy
23,665
+1,721
+8% +$14.6K ﹤0.01% 859
2025
Q3
$91.9K Buy
+21,944
New +$140K ﹤0.01% 984

Other funds holding REPL

Ballentine Partners's REPL Position: Q2 2026 in Review

Ballentine Partners increased its Replimune Group (REPL) stake by 1.8% in Q2 2026, buying an estimated $2.45K and bringing the position to 22,046 shares worth $244K. The position accounts for ﹤0.01% of the portfolio, ranked #912.

Ballentine Partners first reported a position in REPL in Q3 2025 and has held it in 4 quarters since. 12 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Ballentine Partners held 22,046 shares of Replimune Group worth $244K as of Q2 2026.
  • Ballentine Partners bought 400 Replimune Group shares in Q2 2026, an estimated $2.45K.
  • Replimune Group made up ﹤0.01% of Ballentine Partners's portfolio in Q2 2026, its #912 holding.
  • Ballentine Partners first reported a position in Replimune Group in Q3 2025 and has held it in 4 quarters since.
  • 12 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.